AstraZeneca’s Tezspire approved in the EU for patients with severe asthma
Tezspire is a maintenance therapy for patients with no phenotype or biomarker limitations
Read More
Author: John Pinching
LEO Pharma receives positive CHMP opinion of Adtralza
Therapy is for the treatment of adolescents with moderate-to-severe atopic dermatitis
Read More
GenScript and Avectas link up to improve non-viral cell therapy processes
The two biotech leaders have embarked on a research project to streamline manufacturing
Read More
CHMP recommends Sanofi and AstraZeneca’s Beyfortus to treat respiratory syncytial virus
Therapy has been developed for the prevention of disease in infants
Read More
Enter today! – International Clinical Researcher of the Year 2023
Celebrating excellence in clinical research for over decades.
Read More- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
